Zhiji Auto
Venture Round in 2024
Zhiji Automobile specializes in the fields of developing and manufacturing electric vehicles. Zhiji Automobile is jointly created by SAIC Group and Alibaba Group. The company was founded in 2020 and is headquartered in Shanghai, China.
Taiyi Guanjia
Seed Round in 2024
Taiyi Guanjia is a company that combines technology and medical health innovation, aiming to enhance the insurance industry and create a robust medical and health ecosystem.
Bang Er Orthopedic
Venture Round in 2023
Zhejiang Bang Er Medical Investment Management Co., Ltd. is a prominent operator of hospitals specializing in orthopedic care and rehabilitation services, established in 2012 in Zhejiang Province, China. The company focuses on the diagnosis and treatment of various orthopedic conditions, including trauma-related injuries, hand and foot surgery, spine surgery, and joint surgery. By offering a comprehensive range of services, Bang Er aims to provide patients with the necessary care and treatment options for their orthopedic ailments, positioning itself as a key player in the healthcare sector of the Yangtze River Delta.
Tripod Preclinical Research
Funding Round in 2023
Tripod Preclinical Research is a Contract Research Organization that specializes in preclinical research services tailored for the biopharmaceutical industry. The company offers a comprehensive range of services, including nonhuman primate disease models, pharmacological efficacy assessments, early drug evaluations, and GLP toxicology. Tripod is committed to supporting global pharmaceutical companies, research and development enterprises, and medical device manufacturers in the evaluation of new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Additionally, the organization provides technology support in areas such as translational medicine, clinical trials, biological analysis, and the management of biological sample banks, ensuring that its clients have the necessary resources to advance their research and development efforts effectively.
Safe Medical Evaluation
Series D in 2022
SAFE Pharmaceutical, officially known as Beijing Saifu Medical Research Institute Co., Ltd., operates as a Contract Research Organization (CRO) specializing in pharmaceutical research and development services. The company collaborates with esteemed institutions such as the Shanghai Institute of Materia Medica and the National Drug Safety Evaluation and Research Center, leveraging their expertise to enhance its operational capabilities. With a core team comprised of experienced researchers from prestigious scientific organizations, SAFE Pharmaceutical offers comprehensive services that include R&D consulting, toxicology evaluations, and clinical trial design. This integrated approach allows pharmaceutical developers to efficiently advance their product research and development initiatives, supported by strong technical expertise and management experience in drug development and GLP compliance.
Nest is a manufacturer of laboratory equipment and consumables primarily focused on the life sciences sector. The company utilizes modern production tools in a large manufacturing facility to create various products, including cytology, microbial detection, and molecular biology consumables. In addition to these offerings, Nest also provides in vitro diagnostic and medical device-related products. By continually researching and developing new fundamental supplies, Nest aims to provide affordable solutions for its customers, ensuring that laboratories have access to essential consumables for their research needs.
MORE Health’s is a heath startup that aims to offer access to the best physicians in the world when they are needed the most; when patients are faced with a critical, potentially life-changing illness, such as cancer or heart disease.
More health started as an incubation project under Chinese conglomerate SanPower Group.
Shanghai Cell Therapy Group
Series C in 2018
Shanghai Cell Therapy Group Co., Ltd. is a leading entity in the healthcare sector, specializing in cell therapy technology since its establishment in 2013 in Shanghai, China. The company provides a comprehensive range of services, including technical consulting, technology transfer, and investment in the field of cell therapy. It operates a cellular diagnosis center that integrates cellular research with treatment services, focusing on the development of tumor immune cell therapy. Additionally, Shanghai Cell Therapy Group is engaged in cellular cold storage, the production of cellular pharmaceuticals, antibody research, and facilitating genetic testing for patients, while also supplying valuable research data to cancer facilities.
Founded in 2014, Atzuche operates a peer-to-peer car rental platform that connects customers with car owners. The company offers real-time vehicle availability, mobile-based booking and verification, insurance integration, and location-based matching, serving urban commuters and travelers seeking short-term, flexible mobility solutions.
Metromile
Corporate Round in 2016
Metromile is a digital auto insurance platform that uses data science to offer personalized policies based on actual mileage driven, providing real-time insights and potential savings of up to 47% compared to traditional insurance methods. It offers features such as automated claims processing, smart driving analytics via its mobile app, and theft tracking.
E Yang Che
Series A in 2016
E Yang Che is an insurance company that provides car owners with online and offline combined services for paint repair, car maintenance, repairs, insurance claims, and other related services. They are concentrating on the "body spray chain maintenance center" franchising model, offering standardized output, and establishing joint storefronts to concentrate on offering services to clients. Their goal is to construct at least 300 high-standard body spray repair centers in the 100 covered cities in the following 12 months.
Metromile
Series D in 2016
Metromile is a digital auto insurance platform that uses data science to offer personalized policies based on actual mileage driven, providing real-time insights and potential savings of up to 47% compared to traditional insurance methods. It offers features such as automated claims processing, smart driving analytics via its mobile app, and theft tracking.
Bochewang
Series B in 2016
Bochewang operates as a professional B2B trading platform focused on motor cars and accessories, catering specifically to professional buyers such as auto repair shops, dismantle shops, used car dealers, and parts sellers. The platform features three primary components: an auction center for selling accident and used vehicles, an automobile showroom for trading repaired cars, and an accessories platform for various auto parts. By facilitating online transactions, Bochewang aims to streamline the buying and selling process for car owners and buyers, enhancing efficiency while reducing the time involved in these transactions. Users can access a variety of services and rights upon completing registration, payment, and authentication on the platform.
Founded in 2014, Atzuche operates a peer-to-peer car rental platform that connects customers with car owners. The company offers real-time vehicle availability, mobile-based booking and verification, insurance integration, and location-based matching, serving urban commuters and travelers seeking short-term, flexible mobility solutions.
E Yang Che
Venture Round in 2015
E Yang Che is an insurance company that provides car owners with online and offline combined services for paint repair, car maintenance, repairs, insurance claims, and other related services. They are concentrating on the "body spray chain maintenance center" franchising model, offering standardized output, and establishing joint storefronts to concentrate on offering services to clients. Their goal is to construct at least 300 high-standard body spray repair centers in the 100 covered cities in the following 12 months.
C-Health
Angel Round in 2015
C-Health is a mobile medical service platform focused on chronic disease management, particularly diabetes. The company offers an online health platform that assists users in tracking and managing their diabetes symptoms effectively. Its application enables users to monitor the impact of their diet and exercise plans on their health, fostering improved communication between patients and healthcare providers. Additionally, C-Health facilitates post-visit care, ensuring users receive ongoing support as they work towards healthier living. Through its innovative approach, C-Health aims to empower individuals to take charge of their health and improve their quality of life.